Literature DB >> 9509278

Diabetes registries and early biological markers of insulin-dependent diabetes mellitus. Belgian Diabetes Registry.

F K Gorus1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9509278     DOI： 10.1002/(sici)1099-0895(199712)13:4<247::aid-dmr196>3.0.co;2-v

Source DB:  PubMed          Journal:  Diabetes Metab Rev        ISSN： 0742-4221


× No keyword cloud information.
  11 in total

1.  Age and sex based genetic locus heterogeneity in type 1 diabetes.

Authors:  A D Paterson; A Petronis
Journal:  J Med Genet       Date:  2000-03       Impact factor: 6.318

2.  Clinical and biological characteristics of diabetic patients under age 40 in Cameroon: relation to autoantibody status and comparison with Belgian patients.

Authors:  Milca Asanghanwa; Frans K Gorus; Ilse Weets; Bart V der Auwera; Folefac Aminkeng; Eric Mbunwe; Patrick Goubert; Katrijn Verhaeghen; Eugene Sobngwi; Janet M Wenzlau; John C Hutton; Daniel G Pipeleers; Bart Keymeulen; Jean-Claude N Mbanya; Chris van Schravendijk
Journal:  Diabetes Res Clin Pract       Date:  2013-11-20       Impact factor: 5.602

3.  The dense core transmembrane vesicle protein IA-2 is a regulator of vesicle number and insulin secretion.

Authors:  Shin-ichi Harashima; Anne Clark; Michael R Christie; Abner Louis Notkins
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-06       Impact factor: 11.205

4.  An important minority of prediabetic first-degree relatives of type 1 diabetic patients derives from seroconversion to persistent autoantibody positivity after 10 years of age.

Authors:  I Vermeulen; I Weets; O Costa; M Asanghanwa; K Verhaeghen; K Decochez; J Ruige; K Casteels; J Wenzlau; J C Hutton; D G Pipeleers; F K Gorus
Journal:  Diabetologia       Date:  2011-11-18       Impact factor: 10.122

5.  Seasonality in clinical onset of type 1 diabetes in belgian patients above the age of 10 is restricted to HLA-DQ2/DQ8-negative males, which explains the male to female excess in incidence.

Authors:  I Weets; L Kaufman; B Van der Auwera; L Crenier; R P A Rooman; C De Block; K Casteels; E Weber; M Coeckelberghs; Z Laron; D G Pipeleers; F K Gorus
Journal:  Diabetologia       Date:  2004-04       Impact factor: 10.122

Review 6.  Should There be Concern About Autoimmune Diabetes in Adults? Current Evidence and Controversies.

Authors:  Jakob Appel Østergaard; Esben Laugesen; R David Leslie
Journal:  Curr Diab Rep       Date:  2016-09       Impact factor: 4.810

7.  The epidemiology of Type 1 diabetes mellitus is not the same in young adults as in children.

Authors:  K O Kyvik; L Nystrom; F Gorus; M Songini; J Oestman; C Castell; A Green; E Guyrus; C Ionescu-Tirgoviste; P A McKinney; D Michalkova; R Ostrauskas; N T Raymond
Journal:  Diabetologia       Date:  2004-02-05       Impact factor: 10.122

8.  Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients.

Authors:  F K Gorus; E V Balti; I Vermeulen; S Demeester; A Van Dalem; O Costa; H Dorchy; S Tenoutasse; T Mouraux; C De Block; P Gillard; K Decochez; J M Wenzlau; J C Hutton; D G Pipeleers; I Weets
Journal:  Clin Exp Immunol       Date:  2013-01       Impact factor: 4.330

9.  Contribution of antibodies against IA-2β and zinc transporter 8 to classification of diabetes diagnosed under 40 years of age.

Authors:  Ilse Vermeulen; Ilse Weets; Milca Asanghanwa; Johannes Ruige; Luc Van Gaal; Chantal Mathieu; Bart Keymeulen; Vito Lampasona; Janet M Wenzlau; John C Hutton; Daniel G Pipeleers; Frans K Gorus
Journal:  Diabetes Care       Date:  2011-06-29       Impact factor: 19.112

10.  Preexisting insulin autoantibodies predict efficacy of otelixizumab in preserving residual β-cell function in recent-onset type 1 diabetes.

Authors:  Simke Demeester; Bart Keymeulen; Leonard Kaufman; Annelien Van Dalem; Eric V Balti; Ursule Van de Velde; Patrick Goubert; Katrijn Verhaeghen; Howard W Davidson; Janet M Wenzlau; Ilse Weets; Daniel G Pipeleers; Frans K Gorus
Journal:  Diabetes Care       Date:  2015-01-12       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.